Consequently, nitrates, PDE5 inhibitors, or sGC stimulators can improve these diseases, as revealed by the approval of nitrates for angina pectoris, PDE5 inhibitors, and sGC stimulators for pulmonary hypertension and chronic heart failure [19]. Here, PDE5A is linked to pulmonary arterial hypertension.